Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
Active substance factsheet - Last updated: 10/05/2024
imiprothrin (ISO); reaction mass of [2,5-dioxo-3-(prop-2-yn-1-yl)imidazolidin-1-yl]methyl (1R,3S)-2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropanecarboxylate and [2,5-dioxo-3-(prop-2-yn-1-yl)imidazolidin-1-yl]methyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropanecarboxylate
EC number:
428-790-6
CAS number:
72963-72-5
IUPAC name:
BAS number:
1318
Product-type:
PT18
Candidate for substitution:
No
Regulatory categorisation:
Review programme substance
Approval/Assessment status:
Approved
No related authorised products are available
Evaluating competent authority:
United Kingdom
R4BP asset number:
EU-0017563-0000
Legal act:
Start date:
01/07/2019
End date:
30/06/2029
Assessment Report
Study summary
Doc IIIA A7 - Oct 2017.pdf (en)
Doc IIIA A7 Additional imiprothrin soil studies - Oct 2017.pdf (en)
Doc IIIA A6 - Oct 2017.pdf (en)
Doc IIIA A4.1 - Oct 2017.pdf (en)
Doc IIIA A4.2 - Oct 2017.pdf (en)
Doc IIIA A5 - Oct 2017.pdf (en)
Doc IIIA 10.1.3.2 - water sed study - Oct 2017.pdf (en)
Monitoring methods addendum - Oct 2017.pdf (en)
BPC opinions
Imiprothrin_PT 18_SE minority opinion.pdf (en) (19/12/2017)
Imiprothrin_PT 18_Final BPC opinion.pdf (en) (19/12/2017)
Evaluating competent authority:
United Kingdom
Assessment outcome:
Successful
Conclusion date:
19/12/2017
Assessment Report
Study summary
Doc IIIA A7 - Oct 2017.pdf (en)
Doc IIIA A7 Additional imiprothrin soil studies - Oct 2017.pdf (en)
Doc IIIA A6 - Oct 2017.pdf (en)
Doc IIIA A4.1 - Oct 2017.pdf (en)
Doc IIIA A4.2 - Oct 2017.pdf (en)
Doc IIIA A5 - Oct 2017.pdf (en)
Doc IIIA 10.1.3.2 - water sed study - Oct 2017.pdf (en)
Monitoring methods addendum - Oct 2017.pdf (en)
BPC opinions
Imiprothrin_PT 18_SE minority opinion.pdf (en) (19/12/2017)
Imiprothrin_PT 18_Final BPC opinion.pdf (en) (19/12/2017)